Investigative Ophthalmology & Visual Science Cover Image for Volume 48, Issue 11
November 2007
Volume 48, Issue 11
Free
Cornea  |   November 2007
Benefits and Side Effects of Different Vegetable Oil Vectors on Apoptosis, Oxidative Stress, and P2X7 Cell Death Receptor Activation
Author Affiliations
  • Toihiri Said
    From the Laboratoire de Toxicologie and
  • Mélody Dutot
    From the Laboratoire de Toxicologie and
  • Raymond Christon
    INRA (Institut National de la Recherche Agronomique), Lipides Membranaires et Régulation Fonctionnelle du Cœur et des Vaisseaux, UMR (Unite Mixte de Recherche)-INRA Physiologie, Université Paris XI, Châtenay-Malabry, France; and
  • Jean-Louis Beaudeux
    Stress Oxydant et Atteintes Vasculaires, Faculté des Sciences Pharmaceutiques et Biologiques, Université René Descartes Paris, Paris, France;
  • Chantal Martin
    From the Laboratoire de Toxicologie and
  • Jean-Michel Warnet
    From the Laboratoire de Toxicologie and
    INSERM (Institut National de la Santé et de la Recherche Médicale), UMRS (Unité Mixte de Recherche en Santé), Institut Biomédical des Cordeliers, Paris, France.
  • Patrice Rat
    From the Laboratoire de Toxicologie and
    INSERM (Institut National de la Santé et de la Recherche Médicale), UMRS (Unité Mixte de Recherche en Santé), Institut Biomédical des Cordeliers, Paris, France.
Investigative Ophthalmology & Visual Science November 2007, Vol.48, 5000-5006. doi:https://doi.org/10.1167/iovs.07-0229
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Toihiri Said, Mélody Dutot, Raymond Christon, Jean-Louis Beaudeux, Chantal Martin, Jean-Michel Warnet, Patrice Rat; Benefits and Side Effects of Different Vegetable Oil Vectors on Apoptosis, Oxidative Stress, and P2X7 Cell Death Receptor Activation. Invest. Ophthalmol. Vis. Sci. 2007;48(11):5000-5006. https://doi.org/10.1167/iovs.07-0229.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

purpose. Ocular side effects in patients using eye drops may be due to intolerance to the vector used in eye drops. Castor oil is the commonly used lipophilic vector but has been shown to be cytotoxic. Effects on cells of four oils (olive, camelina, Aleurites moluccana, maize) were compared with those of castor oil in human conjunctival cells.

methods. Human conjunctival cells were incubated with the oils for 15 minutes. After a 24-hour recovery period, cells were tested for viability, proliferation, apoptosis (P2X7 cell death receptor and caspase 3 activation), intracellular redox potential, and reactive oxygen species production. Fatty acid incorporation in cell membranes was also analyzed. In vivo ocular irritation was assessed using the Draize test.

results. Compared to the four other oils, castor oil was shown to induce significant necrosis and P2X7 cell death receptor and caspase 3 activation and to enhance intracellular reactive oxygen species production. Aleurites moluccana and camelina oils were not cytotoxic and increased cell membrane omega-3 fatty acid content. None of the five tested oils showed any in vivo ocular irritation.

conclusions. The results demonstrated that castor oil exerts cytotoxic effects on conjunctival cells. This cytotoxicity could explain the side effects observed in some patients using eye drops containing castor oil as a vehicle. The lack of cytotoxic effects observed with the four other oils, Aleurites, camelina, maize, and olive, suggest that they could be chosen to replace castor oil in ophthalmic formulations.

Topical drug administration is very often used to treat ocular surface and intraocular disease, providing higher local drug levels than systemic administration, 1 with minimal general side effects. 2 The therapeutic efficacy of a topical formulation depends on both its composition and the physicochemical properties of the vehicle. Use of an appropriate vehicle is critical to increase the optimal efficacy of the pharmacologically active drug. 3 Most commercialized eye drops are prepared in aqueous form, although most active components are lipophilic. Another drawback of the hydrophilic formulations is the fast elimination of the eye drop by tears, reducing contact duration between the drug and the ocular tissue. 
The use of a lipophilic vehicle in eye drops increases solubility and pharmacologic effects of the drug. An improvement of the cell delivery of drugs using vector oil is based on the modulation of membrane fluidity that directly depends on its fatty acid composition. Castor oil, which mainly contains ricinoleic acid (90% of total fatty acid content), 4 is one of the lipophilic vehicles used in cyclosporine eye drops. 2 5 6 However, it presents both a low-stability and an epithelial and conjunctival toxicity 7 as well as systemic adverse effects such as purgative effects, hypersensitivity, nephrotoxicity, and neurotoxicity. 4 8 Since castor oil is presumed to be responsible for cytotoxic effects in the eye, its replacement by another lipophilic vector could result in better tolerance of the drops. 
Omega-3 fatty acids are important in the structure and function of the visual system. 9 α-Linolenic acid (ALA) is the precursor of the long-chain omega-3 polyunsaturated fatty acids (n-3 PUFA)—mainly, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) 10 —found in fish oils and in nerve tissue cell membranes. Several vegetable oils exhibit a high content of omega-3 fatty acids. For instance, Aleurites moluccana and camelina oils are rich sources of linolenic acid (36%–40%). 11 12 Long-chain omega-3 fatty acids are rapidly incorporated into cell membrane phospholipids, thereby resulting in changes in receptor functions and alteration in cell signaling mechanisms and membrane-bound enzymes. 13 On the other hand, incorporation of α-linolenic acid or other n-3 series fatty acids into the diet results in marked changes in cell membrane composition as well as in arachidonic acid metabolism. 14 Arachidonic acid, a long-chain omega-6 polyunsaturated fatty acid (n-6 PUFA) abundant in membrane phospholipids, is the first step of the inflammatory process after metabolism by cyclooxygenases and lipoxygenases, which are present in the conjunctiva. 15 16 The omega-3 fatty acids contained in vegetable oils, such as camelina oil, could thus replace arachidonic acid in cell membranes and decrease inflammation. Therefore, it is of interest to develop lipophilic vectors that would be free of negative side effects and contain omega-3 fatty acids. 
In this study, we evaluated the in vitro and in vivo toxicity of four vegetable oils to validate their use as vehicles of lipophilic drugs in eye drops. They were chosen because of their biological properties and fatty acid composition 11 17 18 : Two of them are rich in omega-3 fatty acids (Aleurites and camelina) and two are free of omega-3 (maize and olive). The olive oil was highly refined (neutral, denatured, and free of antioxidants) and was chosen as the negative control; castor oil was tested to confirm its cytotoxic effects in our cell model. Cell assays for necrosis, apoptosis, intracellular redox status, and antioxidant properties were performed on human conjunctival cells. In addition, we analyzed the incorporation of oils (i.e., of their constitutive fatty acids) in cultured conjunctival epithelial cell membranes. In vivo ocular irritation was evaluated by using the Draize test. 
Materials and Methods
Reagents
Castor, maize, and olive oils were purchased from Sigma-Aldrich (St. Louis, MO) at the highest purity grade available. Camelina oil was purchased from Phytocos (Poitiers, France); and Aleurites moluccana oil was purchased from Plant Extract Laboratory (Antanarivo, Madagascar). 
Ocular Cytotoxicity Assessment on a Conjunctival Cell Line
Wong Kilbourne–derived human conjunctival epithelial cells (WKD, ECACC 93120839) were cultured under standard conditions (moist atmosphere of 5% CO2 at 37°C) in Dulbecco’s minimum essential medium (DMEM; Eurobio, Les Ulis, France) supplemented with 10% fetal bovine serum (FBS, Eurobio), 2 mM l-glutamine, 50 IU/mL penicillin, and 50 IU/mL streptomycin (Eurobio). The culture medium was changed every 3 days; confluent cultures were removed by trypsin incubation. The cells were counted, seeded into 96-well microplates (Costar; VWR, Fontenay sous Bois, France), and kept at 37°C for 24 hours. The different undiluted oils, including olive oil as the control, were incubated for 15 minutes (30 minutes for the fatty acid incorporation test), and tests were performed after a 24-hour recovery period in culture medium. Olive oil was chosen as the control. 
Fluorometry was performed with a microplate cold light cytofluorometer 19 (Fluorolite 1000; Dynex, Cergy Pontoise, France). All fluorescent dyes were added to living cells, since this method allows detection of the fluorescent signal directly from the microplate. 
Cell Viability
Membrane Integrity.
Membrane integrity, which is closely correlated with cell viability, was evaluated with neutral red (Fluka, Buchs, Switzerland), by fluorometric detection (λexcitation [ex.] = 535 nm; λemission [em.] = 600 nm). Neutral red was used at a concentration of 50 (g/mL, according to Borenfreund and Puerner 20 ; 200 μL per well of medium containing neutral red was added to living cells, and the microplate was incubated for 3 hours at 37°C in moist atmosphere with 5% CO2. The neutral red fluorescence was then measured. 
Redox Status.
The Alamar blue assay was used to measure redox status variations. 21 22 Alamar blue penetrates cells passively and thereby is reduced. The oxidized nonfluorescent dye becomes a reduced fluorescent dye. A solution at 0.1 mg/mL in PBS is diluted (1/11) in culture medium containing 2.5% FBS. Cells were incubated at 37°C for 7 hours, and fluorescence detection (λex. = 535 nm; λem. = 600 nm) was then measured. 
Cell Proliferation.
Cell proliferation was evaluated by the incorporation of BrdU in DNA during replication. The BrdU kit (Cell Proliferation ELISA, BrdU) was provided by Roche (Meylan, France). 
Apoptosis
P2X7 Cell Death Receptor Activation: the YO-PRO-1 Test.
YO-PRO-1, a DNA probe (Invitrogen-Molecular Probes, PoortGebouw, The Netherlands), penetrates apoptotic cells only through the P2X7 receptor. After incubation with the different oils, a 2-μM YO-PRO-1 solution in phosphate-buffered saline was applied (200 μL per well), and the microplate was placed for 10 minutes in the dark at room temperature. The fluorescence signal was scanned by using a cytofluorometer with a small band pass and precise wave lengths for YO-PRO-1 fluorescence detection (λex. = 491 nm; λem. = 509 nm). This test was simultaneously performed with the neutral red test. 
Caspase 3 Activation.
To assess apoptosis, caspase 3 activity was evaluated by using a caspase 3 kit assay with rhodamine 110-DEVD fluorogenic substrate (Invitrogen-Molecular Probes). 
Reactive Oxygen Species Production
Intracellular reactive oxygen species (ROS) production (mainly H2O2) was detected with the 2′,7′-dichlorofluorescein diacetate fluoroprobe (DCFH-DA; Invitrogen-Molecular Probes). 23 This probe is a nonfluorescent compound currently used in flow cytometry and adapted for use in the microplate assay. 24 Once incorporated into the cells, the probe is cleaved by endogenous esterases and can no longer exit the cell. The de-esterified product becomes a fluorescent compound 2′,7′-dichlorofluorescein after its oxidation by intracellular ROS. Fluorescent signal detected (λex.: 490 nm; λem.: 535 nm) is proportional to ROS production. 
Fatty Acid Incorporation in Membrane
The cells were centrifuged for 5 minutes at 1000g. The cell pellets were resuspended in 1 mL of 0.1 M sucrose-10 mM Tris buffer (pH 7.4) at 4°C. They were then lysed after five freeze–thaw cycles and a cold sonication for 30 to 60 seconds. Cell membranes were isolated by several ultracentrifugations. Total lipids were extracted, and membrane fatty acids were analyzed and quantified by high-pressure liquid chromatography, as previously described. 25 26  
In Vivo Assessment of Ocular Irritation: Draize Test
All procedures in this study were performed in compliance with the ARVO Statement for the Use of Animals in Ophthalmic and Visual Research. Animal care and experimentation complied with the rules of European Council Guidelines: license for experimental studies on living animals. Eight-week-old male New-Zealand rabbits (Cegav, Saint Mars d’Egrenne, France) were placed in an individual cage and kept in standard laboratory conditions (at 20°C, 12-hour light–dark cycle), fed ad libitum on the standard laboratory diet with free access to water. 
Ocular irritation was evaluated by a modified Draize test. 27 Briefly, 0.1 mL of nondiluted (100%) oil was instilled into the conjunctival sac, and the upper and lower lids were gently held together for 10 seconds. The opposite eye of each animal served as the untreated control. Ocular responses (conjunctiva, iris, cornea) were scored at 1, 24, 48, 72, and 96 hours, and at 7 days. A fluorescein stain was used to confirm corneal effects visible by examination at the 24-hour observation and at each subsequent observation period until the cornea failed to exhibit uptake of fluorescein. Irritation was scored according to the method of Draize et al. 27 A score of less than 15 was considered to show that the oil was a nonirritant. 
Statistical Analysis
Results were obtained in arbitrary fluorescence units and expressed as a percentage of control values. For cell experiments, oils were tested in six wells, and each experiment was performed in triplicate. Mean values for each concentration were analyzed by one-way ANOVA followed by the Dunnett test. 28 29 All statistical analyses were performed with commercial software (Sigma Stat 2.0; SPSS, Chicago, USA). P < 0.05 was considered statistically significant. 
Results
Cell Viability, Apoptosis, and Oxidative Stress
Cell viability results, as evaluated with the neutral red assay (Fig. 1) , indicated that maize, Aleurites moluccana, and camelina oils did not induce any cellular necrosis when compared with the control olive oil. Although an increase in neutral red incorporation was observed for the three oils when compared with olive oil, no proliferative effect was detected by the specific proliferation BrdU assay (Fig. 2) . On the other hand, the neutral red and BrdU assays indicate that castor oil significantly decreased cell viability (P < 0.001). In the same way, assays for apoptosis revealed that maize, Aleurites moluccana, and camelina oils did not activate the P2X7 cell death receptor and caspase 3 (Fig. 3) , whereas castor oil significantly induced apoptosis through both P2X7 cell death receptor activation (+200%, P < 0.001; Fig. 4 ) and caspase 3 activation (+301%, P < 0.001; Fig. 3 ). 
Finally, when compared with control olive oil, maize, Aleurites moluccana, and camelina oils did not alter intracellular redox status, whereas castor oil significantly decreased intracellular redox potential (−42.3%; Fig. 5 ). Assays with the H2O2-sensitive DCF fluorogenic probe confirmed that castor oil, but not other oils, significantly increased intracellular ROS production (+1400%; Fig. 6 ) that was surely responsible for the alteration of global redox status measured by the Alamar blue assay. 
Fatty Acid Incorporation in Membranes
When compared with olive oil, cells incubated with camelina or Aleurites oils significantly increased the incorporation rate of α-linolenic acid in their membranes, and concomitantly, a decrease in the membrane arachidonic acid content was observed (Table 1) . Because of the strong necrotic effect of castor oil, the modification in membrane fatty acid composition of cells maintained for 30 minutes in the presence of this oil was impossible to determine in our experimental conditions. 
In Vivo Assessment of Ocular Irritation: Draize Test
As indicated in Table 2 , none of the five tested oils induced any noticeable in vivo ocular irritation. For each oil, the score remained ≤2, whereas positivity for this test corresponds to a score of ≧15 or higher. 
Discussion
The results of our study demonstrate that castor oil exhibited significant in vitro cell toxicity in comparison with olive oil. Other tested oils (i.e., camelina, Aleurites moluccana, and maize oils) did not exhibit such deleterious effects, since there was no difference in the necrotic and apoptotic processes or the alteration of ROS production between these oils and olive oil. 
When it occurs, eye drop intolerance can result from either the active component or the vehicle. As an example, benzalkonium chloride, a well-known preservative, is known to induce apoptosis in certain ocular cells; recent published studies from our laboratory demonstrated that benzalkonium chloride activates P2X7 cell death receptor, leading to fluoroquinolone eye drop intolerance. 30 Available cyclosporine eye drops contain maize oil or castor oil as the vehicle. 31 Reports indicate that ophthalmic formulations containing castor oil are more cytotoxic than those containing maize oil. 32 Our present results showed that castor oil induced necrosis, apoptosis (P2X7 receptor and caspase 3 activations), and intracellular H2O2 overproduction in an in vitro model of conjunctival cells. As a hypothesis, the cytotoxic effects of castor oil could be due to its high ricinoleic acid content. 
Indeed, high concentrations of ricinoleic acid (≥0.1 mM) were shown to be cytotoxic in isolated hamster intestinal epithelial cells. 4 The lack of in vivo toxicity (Draize test) may be due to the single application of castor oil, which is not sufficient to induce a toxic effect and ocular irritation. As a further study, in vivo assays testing repeated applications of castor oil (as well as ricinoleic acid) might show toxicity and explain clinical observations. Indeed, some patients who use eye drops containing castor oil exhibit discomfort and ocular irritation after long-term treatment. Use of nontoxic lipophilic eye drop vehicles, instead of castor oil, could suppress such adverse effects. The other tested oils presented better in vitro tolerance than castor oil and could be used in ophthalmic formulations instead of castor oil. Maize oil is not cytotoxic and is already used in cyclosporine eye drop preparations at the French Ophthalmologic National Center (Hôpital des Quinze-Vingts, Paris, France). Our in vitro results confirm the tolerance of this oil and suggest that long-term treatment of patients would be safe. 
Omega-3 fatty acids are critical for membrane functions and were shown to exhibit anti-inflammatory effects. 33 In response to proinflammatory stimuli, enhanced catalytic activity of phospholipase A2 degrades membrane phospholipids to form free arachidonic acid that is converted into prostaglandins and other eicosanoids through activation of the oxidative enzymes cyclooxygenases and lipoxygenases. All these enzymes are found in ocular conjunctiva. 34 35 36 37 Replacement of arachidonic acid by DHA and EPA in cell membranes reduces the inflammatory process related to proinflammatory prostaglandin synthesis, since products of the catalytic action of phospholipase A2, cyclooxygenases, and lipoxygenases more likely result in the formation of anti-inflammatory 38 and proresolving than proinflammatory products, 39 40 especially in the retina. 41 As another beneficial effect of the membrane enrichment in omega-3, modification of membrane fatty acids is responsible for quantitative and/or qualitative changes in lipid raft domain activity. Lipid rafts consist of lateral assemblies of cholesterol and sphingolipids in the outer exoplasmic leaflet connected to phospholipids and cholesterol in the inner cytoplasmic leaflet of the membrane bilayer. Components of the death-inducing signaling complex have been shown to be present in the raft fraction. 42  
Both Aleurites moluccana and camelina oils have a high content of omega-3 fatty acids (35% and 40% of total fatty acids, respectively), which may precipitate a better tolerance and efficacy of the drug, improving cell membrane fluidity, and drug incorporation. These oils should be considered as interesting candidates for alternative lipophilic vehicles in eye drop formulations, since our data showed that they did not exhibit in vitro and in vivo toxic effects and contributed to beneficial changes in cell membrane fatty acid composition (i.e., depletion in arachidonic acid and a substantial enrichment of cell membranes in ALA; Table 1 ). 
Conclusion
In our in vitro experimental conditions, castor oil induced necrosis and apoptosis and enhanced oxidative stress, which could contribute to the side effects of eye drops containing this oil as a vehicle. Aleurites moluccana and camelina oils did not exhibit such cell deleterious effects and may exert beneficial actions on both inflammatory process and drug incorporation by decreasing membrane content in arachidonic acid on behalf of omega-3 acids. The innocuous effects of these oils allow their potential use as novel vehicles for eye drops that require lipophilic vectors. 
 
Figure 1.
 
Membrane integrity evaluation using the neutral red test after incubation with different oils for 15 minutes followed by a 24-hour recovery period. Results are expressed as a percentage of control. Castor oil decreased cell viability. *P < 0.001.
Figure 1.
 
Membrane integrity evaluation using the neutral red test after incubation with different oils for 15 minutes followed by a 24-hour recovery period. Results are expressed as a percentage of control. Castor oil decreased cell viability. *P < 0.001.
Figure 2.
 
Cell proliferation evaluation with BrdU incorporation after incubation with different oils for 15 minutes followed by a 24-hour recovery period. Castor oil inhibited cell proliferation. *P < 0.001.
Figure 2.
 
Cell proliferation evaluation with BrdU incorporation after incubation with different oils for 15 minutes followed by a 24-hour recovery period. Castor oil inhibited cell proliferation. *P < 0.001.
Figure 3.
 
Caspase 3 activity evaluated by the rhodamine 110-DEVD fluorogenic substrate after incubation with different oils for 15 minutes followed by a 24-hour recovery period. Results are expressed as a percentage of the control. Castor oil activated caspase 3. *P < 0.001.
Figure 3.
 
Caspase 3 activity evaluated by the rhodamine 110-DEVD fluorogenic substrate after incubation with different oils for 15 minutes followed by a 24-hour recovery period. Results are expressed as a percentage of the control. Castor oil activated caspase 3. *P < 0.001.
Figure 4.
 
P2X7 cell death receptor activation evaluated with the YO-PRO-1 test after incubation with different oils for 15 minutes followed by a 24-hour recovery period. Results are expressed as a percentage of the control. Castor oil activated P2X7 cell death receptor. *P < 0.001.
Figure 4.
 
P2X7 cell death receptor activation evaluated with the YO-PRO-1 test after incubation with different oils for 15 minutes followed by a 24-hour recovery period. Results are expressed as a percentage of the control. Castor oil activated P2X7 cell death receptor. *P < 0.001.
Figure 5.
 
Redox status evaluation using the Alamar blue test after incubation with different oils for 15 minutes followed by a 24-hour recovery period. Results are expressed as a percentage of the control. Castor oil altered intracellular redox status. *P < 0.001.
Figure 5.
 
Redox status evaluation using the Alamar blue test after incubation with different oils for 15 minutes followed by a 24-hour recovery period. Results are expressed as a percentage of the control. Castor oil altered intracellular redox status. *P < 0.001.
Figure 6.
 
ROS production evaluated by DCF-DA test after incubation with different oils for 15 minutes followed by a 24-hour recovery period. Results are expressed in DCF/NR fluorescence ratio. Castor oil increased ROS production. *P < 0.001.
Figure 6.
 
ROS production evaluated by DCF-DA test after incubation with different oils for 15 minutes followed by a 24-hour recovery period. Results are expressed in DCF/NR fluorescence ratio. Castor oil increased ROS production. *P < 0.001.
Table 1.
 
Fatty Acid Incorporation in Conjunctival Cell Membranes after Incubation with Different Oils
Table 1.
 
Fatty Acid Incorporation in Conjunctival Cell Membranes after Incubation with Different Oils
Fatty Acid Control Olive Maize Camelina Aleurites
Arachidonic acid 20:4 (n-6) 6.75 4.62 4.45 4.09 1.65
α-Linolenic acid 18:3 (n-3) 0.60 0.60 2.82 7.20 13.52
Table 2.
 
In Vivo Ocular Irritation Score
Table 2.
 
In Vivo Ocular Irritation Score
Oils 1 h 24 h 48 h 72 h 96 h 7 d Total Comparison Observations
Olive 0 0 0 0 0 0 0 <15 No irritant
Castor 2 0 0 0 0 0 2 <15 No irritant
Maize 1 0 0 0 0 0 1 <15 No irritant
Aleurites moluccana 0 0 0 0 0 0 0 <15 No irritant
Camelina 0 0 0 0 0 0 0 <15 No irritant
LallemandF, Felt-BaeyensO, BesseghirK, Behar-CohenF, GurnyR. Cyclosporine A delivery to the eye: a pharmaceutical challenge. Eur J Pharm Biopharm. 2003;56:307–318. [CrossRef] [PubMed]
MostellerMW, GebhardtBM, HamiltonAM, KaufmanHE. Penetration of topical cyclosporine into the rabbit cornea, aqueous humor, and serum. Arch Ophthalmol. 1985;103:101–102. [CrossRef] [PubMed]
OzsoyY, GungorS, CevherE. Vehicle effects on in vitro release of tiaprofenic acid from different topical formulations. Farmaco. 2004;59:563–566. [CrossRef] [PubMed]
BurdockGA, CarabinIG, GriffithsJC. Toxicology and pharmacology of sodium ricinoleate. Food Chem Toxicol. 2006;44:1689–1698. [CrossRef] [PubMed]
WiederholtM, KossendrupD, SchulzW, HoffmannF. Pharmacokinetic of topical cyclosporin A in the rabbit eye. Invest Ophthalmol Vis Sci. 1986;27:519–524. [PubMed]
KanpolatA, BatiogluF, YilmazM, AkbasF. Penetration of cyclosporin A into the rabbit cornea and aqueous humor after topical drop and collagen shield administration. CLAO J. 1994;20:119–122. [PubMed]
BrignoleF, PisellaPJ, De Saint JeanM, GoldschildM, GoguelA, BaudouinC. Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A. Invest Ophthalmol Vis Sci. 2001;42:90–95. [PubMed]
CrosassoP, CerutiM, BrusaP, ArpiccoS, DosioF, CattelL. Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes. J Control Release. 2000;63:19–30. [CrossRef] [PubMed]
UauyR, MenaP, RojasC. Essential fatty acids in early life: structural and functional role. Proc Nutr Soc. 2000;59:3–15. [CrossRef] [PubMed]
FlachsP, HorakovaO, BraunerP, et al. Polyunsaturated fatty acids of marine origin upregulate mitochondrial biogenesis and induce beta-oxidation in white fat. Diabetologia. 2005;48:2365–2375. [CrossRef] [PubMed]
KarvonenHM, AroA, TapolaNS, SalminenI, UusitupaMI, SarkkinenES. Effect of alpha-linolenic acid-rich camelina sativa oil on serum fatty acid composition and serum lipids in hypercholesterolemic subjects. Metab Clin Exp. 2002;51:1253–1260. [CrossRef] [PubMed]
JiaQ, ShiY, BenninkMB, PestkaJJ. Docosahexaenoic acid and eicosapentaenoic acid, but not alpha-linolenic acid, suppress deoxynivalenol-induced experimental IgA nephropathy in mice. J Nutr. 2004;134:1353–1361. [PubMed]
SinclairAJ, MurphyKJ, LiD. Marine lipids: overview “news insights and lipid composition of Lyprinol”. Allerg Immunol. 2000;32:261–271.
MorrisDD, HenryMM, MooreJN, FischerK. Effect of dietary linolenic acid on endotoxin-induced thromboxane and prostacyclin production by equine peritoneal macrophages. Circ Shock. 1989;29:311–318. [PubMed]
WilliamsRN, BhattacherjeeP, EakinsKE. Biosynthesis of lipoxygenase products by ocular tissues. Exp Eye Res. 1983;36:397–402. [CrossRef] [PubMed]
KulkarniPS, SrinivasanBD. Cyclooxygenase and lipoxygenase pathways in anterior uvea and conjunctiva. Prog Clin Biol Res. 1989;312:39–52. [PubMed]
SatyanarayanaP, KumarKA, SinghSK, RaoGN. A new phorbol diester from Aleurites moluccana. Fitoterapia. 2001;72:304–306. [CrossRef] [PubMed]
LocherCP, BurchMT, MowerHF, et al. Anti-microbial activity and anticomplement activity of extracts obtained from selected Hawaiian medicinal plants. J Ethnopharmacol. 1995;49:23–32. [CrossRef] [PubMed]
RatP, Korwin-ZmijowskaC, WarnetJM, AdolpheM. New in vitro fluorimetric microtitration assays for toxicological screening of drugs. Cell Biol Toxicol. 1994;10:329–337. [CrossRef] [PubMed]
BorenfreundE, PuernerJ. A simple quantitative procedure using monolayer cultures for cytotoxicity assay (HTD/NR-90). Methods Cell Sci. 1985;9:7–9.
LarsonEM, DoughmanDJ, GregersonDS, ObritschWF. A new, simple, nonradioactive, nontoxic in vitro assay to monitor corneal endothelial cell viability. Invest Ophthalmol Vis Sci. 1997;38:1929–1933. [PubMed]
de FriesR, MitsuhashiM. Quantification of mitogen induced human lymphocyte proliferation: comparison of Alamar blue assay to 3H-thymidine incorporation assay. J Clin Lab Anal. 1995;9:89–95. [CrossRef] [PubMed]
BrubacherJL, BolsNC. Chemically de-acetylated 2′,7′-dichlorodihydrofluorescein diacetate as a probe of respiratory burst activity in mononuclear phagocytes. J Immunol Methods. 2001;251:81–91. [CrossRef] [PubMed]
DebbaschC, BrignoleF, PisellaPJ, WarnetJM, RatP, BaudouinC. Quaternary ammoniums and other preservatives’ contribution in oxidative stress and apoptosis on Chang conjunctival cells. Invest Ophthalmol Vis Sci. 2001;42:642–652. [PubMed]
ChristonRA. Mechanisms of action of dietary fatty acids in regulating the activation of vascular endothelial cells during atherogenesis. Nutr Rev. 2003;61:272–279. [CrossRef] [PubMed]
LinardA, MacaireJ, ChristonR. Phospholipid hydroperoxide glutathione peroxidase activity and vitamin E level in the liver microsomal membrane: effects of age and dietary alpha-linolenic acid deficiency. J Nutr Biochem. 2001;12:481–491. [CrossRef] [PubMed]
DraizeJH, WoodardG, CalveryHO. Method for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther. 1944;82:377–390.
DunnettC. A multiple comparison procedure for comparing several treatments with a control. J Am Stat Assoc. 1955;50:1096–1121. [CrossRef]
DunnettC. New tables for multiple comparison with a control. Biometrics. 1964;20:782–791,782–791.
DutotM, PouzaudF, LaroscheI, Brignole-BaudouinF, WarnetJM, RatP. Fluoroquinolone eye drop-induced cytotoxicity: role of preservative in P2X7 cell death receptor activation and apoptosis. Invest Ophthalmol Vis Sci. 2006;47:2812–2819. [CrossRef] [PubMed]
AcheampongAA, ShackletonM, Tang-LiuDD, DingS, SternME, DeckerR. Distribution of cyclosporin A in ocular tissues after topical administration to albino rabbits and beagle dogs. Curr Eye Res. 1999;18:91–103. [CrossRef] [PubMed]
NourryH, PerrotS, MartinC, et al. Cytotoxicity evaluation of different eyes drops with cyclosporine oral solution (Sandimmun) (in French). J Fr Ophtalmol. 2006;29:251–257. [CrossRef] [PubMed]
MunstermanAS, BertoneAL, ZachosTA, WeisbrodeSE. Effects of the omega-3 fatty acid, alpha-linolenic acid, on lipopolysaccharide-challenged synovial explants from horses. Am J Vet Res. 2005;66:1503–1508. [CrossRef] [PubMed]
KulkarniPS, RodriguezAV, SrinivasanBD. Human anterior uvea synthesizes lipoxygenase products from arachidonic acid. Invest Ophthalmol Vis Sci. 1984;25:221–223. [PubMed]
WoodwardDF, NievesAL, HawleySB, JosephR, MerlinoGF, SpadaCS. The pruritogenic and inflammatory effects of prostanoids in the conjunctiva. J Ocul Pharmacol Ther. 1995;11:339–347. [CrossRef] [PubMed]
KulkarniPS, FleisherL, SrinivasanBD. The synthesis of cyclooxygenase products in ocular tissues of various species. Curr Eye Res. 1984;3:447–452. [CrossRef] [PubMed]
SolomonA, DursunD, LiuZ, XieY, MacriA, PflugfelderSC. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci. 2001;42:2283–2292. [PubMed]
PalomboJD, DeMicheleSJ, LydonE, BistrianBR. Cyclic vs continuous enteral feeding with omega-3 and gamma-linolenic fatty acids: effects on modulation of phospholipid fatty acids in rat lung and liver immune cells. JPEN J Parenter Enteral Nutr. 1997;21:123–132. [CrossRef] [PubMed]
NievesD, MorenoJJ. Effect of arachidonic and eicosapentaenoic acid metabolism on RAW 264.7 macrophage proliferation. J Cell Physiol. 2006;208:428–434. [CrossRef] [PubMed]
ChiangN, SerhanCN. Cell-cell interaction in the transcellular biosynthesis of novel omega-3-derived lipid mediators. Methods Mol Biol. 2006;341:227–250. [PubMed]
SanGiovanniJP, ChewEY. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retinal Eye Res. 2005;24:87–138. [CrossRef]
Scheel-ToellnerD, WangK, SinghR, et al. The death-inducing signalling complex is recruited to lipid rafts in Fas-induced apoptosis. Biochem Biophys Res Commun. 2002;297:876–879. [CrossRef] [PubMed]
Figure 1.
 
Membrane integrity evaluation using the neutral red test after incubation with different oils for 15 minutes followed by a 24-hour recovery period. Results are expressed as a percentage of control. Castor oil decreased cell viability. *P < 0.001.
Figure 1.
 
Membrane integrity evaluation using the neutral red test after incubation with different oils for 15 minutes followed by a 24-hour recovery period. Results are expressed as a percentage of control. Castor oil decreased cell viability. *P < 0.001.
Figure 2.
 
Cell proliferation evaluation with BrdU incorporation after incubation with different oils for 15 minutes followed by a 24-hour recovery period. Castor oil inhibited cell proliferation. *P < 0.001.
Figure 2.
 
Cell proliferation evaluation with BrdU incorporation after incubation with different oils for 15 minutes followed by a 24-hour recovery period. Castor oil inhibited cell proliferation. *P < 0.001.
Figure 3.
 
Caspase 3 activity evaluated by the rhodamine 110-DEVD fluorogenic substrate after incubation with different oils for 15 minutes followed by a 24-hour recovery period. Results are expressed as a percentage of the control. Castor oil activated caspase 3. *P < 0.001.
Figure 3.
 
Caspase 3 activity evaluated by the rhodamine 110-DEVD fluorogenic substrate after incubation with different oils for 15 minutes followed by a 24-hour recovery period. Results are expressed as a percentage of the control. Castor oil activated caspase 3. *P < 0.001.
Figure 4.
 
P2X7 cell death receptor activation evaluated with the YO-PRO-1 test after incubation with different oils for 15 minutes followed by a 24-hour recovery period. Results are expressed as a percentage of the control. Castor oil activated P2X7 cell death receptor. *P < 0.001.
Figure 4.
 
P2X7 cell death receptor activation evaluated with the YO-PRO-1 test after incubation with different oils for 15 minutes followed by a 24-hour recovery period. Results are expressed as a percentage of the control. Castor oil activated P2X7 cell death receptor. *P < 0.001.
Figure 5.
 
Redox status evaluation using the Alamar blue test after incubation with different oils for 15 minutes followed by a 24-hour recovery period. Results are expressed as a percentage of the control. Castor oil altered intracellular redox status. *P < 0.001.
Figure 5.
 
Redox status evaluation using the Alamar blue test after incubation with different oils for 15 minutes followed by a 24-hour recovery period. Results are expressed as a percentage of the control. Castor oil altered intracellular redox status. *P < 0.001.
Figure 6.
 
ROS production evaluated by DCF-DA test after incubation with different oils for 15 minutes followed by a 24-hour recovery period. Results are expressed in DCF/NR fluorescence ratio. Castor oil increased ROS production. *P < 0.001.
Figure 6.
 
ROS production evaluated by DCF-DA test after incubation with different oils for 15 minutes followed by a 24-hour recovery period. Results are expressed in DCF/NR fluorescence ratio. Castor oil increased ROS production. *P < 0.001.
Table 1.
 
Fatty Acid Incorporation in Conjunctival Cell Membranes after Incubation with Different Oils
Table 1.
 
Fatty Acid Incorporation in Conjunctival Cell Membranes after Incubation with Different Oils
Fatty Acid Control Olive Maize Camelina Aleurites
Arachidonic acid 20:4 (n-6) 6.75 4.62 4.45 4.09 1.65
α-Linolenic acid 18:3 (n-3) 0.60 0.60 2.82 7.20 13.52
Table 2.
 
In Vivo Ocular Irritation Score
Table 2.
 
In Vivo Ocular Irritation Score
Oils 1 h 24 h 48 h 72 h 96 h 7 d Total Comparison Observations
Olive 0 0 0 0 0 0 0 <15 No irritant
Castor 2 0 0 0 0 0 2 <15 No irritant
Maize 1 0 0 0 0 0 1 <15 No irritant
Aleurites moluccana 0 0 0 0 0 0 0 <15 No irritant
Camelina 0 0 0 0 0 0 0 <15 No irritant
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×